BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

Benzinga Newsdesk www.benzinga.com Positive 67.6%

Neg 0% Neu 0% Pos 67.6%

BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.